方法：以2011-11/2013-09因翼状胬肉在我院接受手术治疗的124例134眼患者为研究对象，随机分为试验组(双氯芬酸钠滴眼液+玻璃酸钠滴眼液)和对照组(妥布霉素地塞米松滴眼液+玻璃酸钠滴眼液)，术后每周随访1次，历时3mo，对两组角膜状况、眼压和翼状胬肉复发情况进行对比观察和统计学分析。

结果：随访3mo，按计划完成随访的试验组有43例45眼，对照组有38例39眼，其中出现复发迹象的试验组有14例15眼，最终复发2例3眼，与对照组12例13眼出现复发迹象，最终复发2例2眼相比，两组差异无统计学意义( P>0.05)； 对照组有6例9眼因修正眼压高于正常上限值退出试验，与试验组(0眼)相比，差异有统计学意义(P<0.05)； 两组间角膜情况比较差异无统计学意义(P>0.05)。

结论：双氯芬酸钠滴眼液控制翼状胬肉术后复发是有效且安全的。

METHODS: From November 2011 to September 2013, 124 patients 134 eyes who underwent surgery because of pterygium in our hospital were randomly divided into trial group( diclofenac sodium eye drops and sodium hyaluronate eye drops)and control group(tobramycin dexamethasone eye drops and sodium hyaluronate eye drops), all patients were followed up for 3mo(once a week)and the cornea, intraocular pressure and recurrence of pterygium were observed and compared between the two groups.

RESULTS: Followed up for 3mo, 43 cases(45 eyes)in the trial group and 38 cases(39 eyes)in the control group had done the follow up as planned, in which 14 cases(15 eyes)showed the signs of recurrence, 2 cases(3 eyes)recurred eventually in the trial group, and in the meantime there were 12 cases(13 eyes)with signs of recurrence and 2 cases(2 eyes)with a recurrence eventually in the control group, but no statistical difference was found between the two groups(P>0.05); there were 6 cases(9 eyes)dropped out of the study with a higher intraocular pressure in the control group, compared to trial group(0 cases of 0 eye), the difference was statistically significant(P<0.05); cornea conditions between the two groups had no statistical significance(P>0.05).

CONCLUSION:Diclofenac sodium eye drops is effective and safe in preventing the recurrence of pterygium.